Login
Super Investors / Sands Capital Alternatives, LLC
SC

Sands Capital Alternatives, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$614M
Positions
24
Quarter ended
June 30, 2026
Filed
August 13, 2026

Reported portfolio value by quarter (20 quarters reported)

$675M $299M
Q3 21 Q3 22 Q3 23 Q3 24 Q3 25 Q2 26

$663M in Q3 2021 → $614M now. Hover for any quarter.

Holdings

As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Alamar Biosciences Inc 18.7% New 4,230,926 $115M
NH Nu Hldgs Ltd 15.4% Added 8.5% 7,094,952 $94.8M
Klaviyo Inc 9.7% Added 7.6% 3,928,146 $59.3M
Beta Bionics Inc 9.5% Unchanged 3,708,043 $58.1M
Spyglass Pharma Inc 9.1% Unchanged 2,500,012 $55.7M
Inhibikase Therapeutics Inc 4.3% Unchanged 13,018,965 $26.4M
Doordash Inc 3.8% Added 15% 127,562 $23.5M
Coupang Inc 3.8% Added 31% 1,329,314 $23.1M
Datadog Inc 3.4% Trimmed 5.8% 80,851 $21.1M
Bioage Labs Inc 3.1% Unchanged 786,353 $19.3M
10x Genomics Inc 3.0% Unchanged 481,770 $18.5M
Samsara Inc 2.7% Trimmed 8.0% 515,658 $16.7M
Odyssey Therapeutics Inc 2.7% New 875,000 $16.4M
Toast Inc 1.7% Added 21% 364,879 $10.2M
Acumen Pharmaceuticals Inc 1.6% Unchanged 3,720,105 $9.93M
Servicetitan Inc 1.3% Added 21% 108,545 $7.68M
Cerebras Systems Inc 1.2% New 32,825 $7.25M
Snowflake Inc 1.0% Added 21% 24,498 $6.23M
Monday Com Ltd 1.0% Added 21% 81,982 $5.93M
Tarsus Pharmaceuticals Inc 0.9% Unchanged 85,000 $5.35M
Taysha Gene Therapies Inc 0.8% Unchanged 724,873 $4.94M
Candel Therapeutics Inc 0.7% Unchanged 405,837 $4.18M
Acrivon Therapeutics Inc 0.7% Added 7.9% 2,289,271 $4.07M
Figma Inc 0.1% Added 21% 22,165 $401K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q2 2026

quarter ended June 30, 2026 · filed August 13, 2026

Company Action Shares changed Value of change % of portfolio
Alamar Biosciences Inc New +4,230,926 +$115M 18.7%
Odyssey Therapeutics Inc New +875,000 +$16.4M 2.7%
NH Nu Hldgs Ltd Added +557,183 +$7.44M 15.4%
Cerebras Systems Inc New +32,825 +$7.25M 1.2%
Coupang Inc Added +317,223 +$5.51M 3.8%
Klaviyo Inc Added +278,468 +$4.2M 9.7%
Doordash Inc Added +16,331 +$3.01M 3.8%
Toast Inc Added +63,232 +$1.76M 1.7%
Samsara Inc Trimmed −44,629 −$1.45M 2.7%
Servicetitan Inc Added +18,689 +$1.32M 1.3%

Showing the 10 largest of 15 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 08, 2026

Company Action Shares changed Value of change % of portfolio
Spyglass Pharma Inc New +2,500,012 +$64.8M 15.4%
NH Nu Hldgs Ltd Trimmed −323,630 −$4.65M 22.3%
Samsara Inc Added +94,097 +$2.98M 4.2%
Coupang Inc Added +141,667 +$2.67M 4.5%
Doordash Inc Added +15,613 +$2.34M 4.0%
Beta Bionics Inc Added +137,930 +$1.38M 8.8%
Acumen Pharmaceuticals Inc Added +303,030 +$715K 2.1%

Q4 2025

quarter ended December 31, 2025 · filed February 13, 2026

Company Action Shares changed Value of change % of portfolio
Servicetitan Inc New +89,856 +$9.57M 1.8%
CH Crowdstrike Hldgs Inc Exited −15,615 −$7.66M
Tarsus Pharmaceuticals Inc Trimmed −85,000 −$6.96M 1.3%
NH Nu Hldgs Ltd Trimmed −314,035 −$5.26M 22.2%
Toast Inc Added +145,043 +$5.15M 2.1%
Samsara Inc Trimmed −132,724 −$4.71M 3.2%
Datadog Inc Trimmed −32,914 −$4.48M 2.3%
Klaviyo Inc Added +134,613 +$4.37M 22.9%
Inhibikase Therapeutics Inc Added +2,068,965 +$4.24M 5.1%
Coupang Inc Added +75,418 +$1.78M 4.0%

Showing the 10 largest of 13 changes.

Q3 2025

quarter ended September 30, 2025 · filed November 13, 2025

Company Action Shares changed Value of change % of portfolio
Doordash Inc Trimmed −291,060 −$79.2M 5.4%
Samsara Inc Added +160,429 +$5.98M 4.9%
Coupang Inc Trimmed −54,025 −$1.74M 5.6%
Figma Inc New +18,286 +$948K 0.2%

Q2 2025

quarter ended June 30, 2025 · filed August 13, 2025

Company Action Shares changed Value of change % of portfolio
Samsara Inc Added +185,053 +$7.36M 3.4%
Beta Bionics Inc Added +466,331 +$6.79M 10.2%
Uipath Inc Exited −395,855 −$4.08M
Monday Com Ltd Added +8,428 +$2.65M 3.6%
Klaviyo Inc Added +71,550 +$2.4M 23.2%
Toast Inc Trimmed −54,007 −$2.39M 1.4%
Coupang Inc Added +5,555 +$166K 5.0%
NH Nu Hldgs Ltd Added +11,079 +$152K 19.4%
Doordash Inc Added +498 +$123K 18.5%
Datadog Inc Added +777 +$104K 3.1%

Showing the 10 largest of 12 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 14, 2025

Company Action Shares changed Value of change % of portfolio
Beta Bionics Inc New +3,103,782 +$38M 9.3%
Uipath Inc Trimmed −1,188,822 −$12.2M 1.0%
Doordash Inc Trimmed −26,639 −$4.87M 17.0%
Samsara Inc Added +54,742 +$2.1M 2.4%
Datadog Inc Added +20,142 +$2M 2.9%
Coupang Inc Trimmed −81,236 −$1.78M 4.5%
Snowflake Inc Trimmed −12,179 −$1.78M 1.0%
NH Nu Hldgs Ltd Added +143,196 +$1.47M 17.9%
Klaviyo Inc Trimmed −27,179 −$822K 25.5%
Toast Inc Trimmed −20,919 −$694K 1.7%

Showing the 10 largest of 14 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 13, 2025

Company Action Shares changed Value of change % of portfolio
Inhibikase Therapeutics Inc New +10,950,000 +$35.6M 7.7%
Coupang Inc Added +912,781 +$20.1M 4.4%
NH Nu Hldgs Ltd Added +1,522,357 +$15.8M 15.8%
Datadog Inc Added +96,382 +$13.8M 3.0%
Monday Com Ltd New +48,278 +$11.4M 2.5%
Snowflake Inc Trimmed −69,297 −$10.7M 1.3%
Samsara Inc Added +195,518 +$8.54M 1.9%
Toast Inc Added +227,077 +$8.28M 1.8%
CH Crowdstrike Hldgs Inc Added +16,879 +$5.78M 1.3%
Uipath Inc Added +429,431 +$5.46M 4.4%

Showing the 10 largest of 15 changes.

Q3 2024

quarter ended September 30, 2024 · filed November 13, 2024

Company Action Shares changed Value of change % of portfolio
NH Nu Hldgs Ltd Trimmed −1,829,492 −$25M 21.1%
Bioage Labs Inc New +1,086,353 +$22.6M 6.4%
Absci Corporation Exited −57,804 −$178K
Samsara Inc Trimmed −1,067 −$51.3K
Datadog Inc Added +391 +$45K
Doordash Inc Added +247 +$35.3K 17.0%
Klaviyo Inc Trimmed −896 −$31.7K 35.0%
Toast Inc Trimmed −492 −$13.9K

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support